Oncoclinicas do Brasil Medical Services () reported on Thursday, 27, that celebrated, with Hapvida Notredame (), a commercial collaboration to offer outpatient care in oncology.
In a statement sent to the Securities Commission (CVM), the company points out that the initiative will benefit more than 600,000 lives in the São Paulo Metropolitan Region and has expansion potential for the interior of the state of São Paulo, as well as other regions such as Minas Gerais, Rio de Janeiro, Rio Grande do Sul and Paraná, in the coming months.
Commercial collaboration also includes the radiotherapy service throughout the national territory, combining oncology oncology expertise with Hapvida Notredame’s integrated care model.